News & Events

2nd Annual Advances in Immuno-Oncology USA Congress

Location: DoubleTree by Hilton Hotel San Diego, Mission Valley, USA Dates: October 8-9, 2019 Booth: #4 Presentation Title: Accelerating Therapeutic Antibody Discovery with Fully Human…

Read more
Experts in Genetically Engineered Animal Development and Maintenance

Time: 10:30-11:30am, Sept. 19th, 2019 Location: Conference Room D1, Building 114, Massachusetts General Hospital, 16th Street, Charlestown MA  02129 Speakers: Daniel Trombly, Ph.D. Gene Editing…

Read more
2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

Location: Hilton Garden Inn Philadelphia Center City Dates: Sept. 19-20, 2019 Booth: #Ex-7 Presentation Title: Accelerating Therapeutic Antibody Discovery and Development with Innovative Humanized Mouse…

Read more
Biocytogen Closes $79M Series D Funding

On August 2019, Beijing Biocytogen Co., Ltd. ("Biocytogen") announced the closing of its Series D funding of $79M (RMB 543M). This round of financing was…

Read more
Symposium: Future of Biologic Drug Discovery and Development

Free to attend, lunch and light dinner will be provided. Join Biocytogen to learn more about the cutting-edge technologies and latest research in biologic drug. The…

Read more
Biocytogen at the ESMO 2018 Annual Meeting

Biocytogen at the at the ESMO 2018 annual meeting, which will take place in Munich, Germany from between 19-23 October 2018.

Read more
Biocytogen’s President & CEO, Dr. Yuelei Shen, Speaks at Harvard China Forum at Harvard University

Harvard College China Forum, an annual Harvard tradition for 22 years, welcomed and opened to 1,200 domestic and international participants and over 100 domestic and…

Read more
Biocytogen’s Integrated One-stop Preclinical Services and the RenMab Mouse Shine at AACR 2019

American Association for Cancer Research (AACR) Annual Meeting 2019 was held in Atlanta, Georgia from March 29 to April 3, 2019, with a theme of “Integrative…

Read more
American Association for Cancer Research (AACR) Annual Meeting 2019

Biocytogen Highlights 10 Posters highlight new IO targets (e.g. CTLA-4, OX40, CD3e), preclinical services, PK/PD studies, and antibody screening platform will be presented at AACR.…

Read more
Former Swedish Prime Minister Visits Biocytogen

Former Swedish Prime Minister, former president of the European Council Mr. Fredrik Reinfeldt and Executive Chairman of Nordic Growth Technology (NGT) Partners, professor Niclas Adler…

Read more
Back to top